Prenatal Testing PRISCA I (from 11 to 13 +6 weeks of pregnancy) | For the Risk Assessment of Down, Edward's, and Patau's Syndromes

Non-invasive blood test for pregnant women, where the concentrations of several biochemical markers and other maternal data are used by computer programs to assess the risk of fetal chromosomal diseases or other malformations.

In the first trimester of pregnancy, the risk is assessed for the baby being born with Down and Edwards syndromes.

We inform you that before performing this test, it is mandatory to have an ultrasound in the same week.